Handelsavisen
prelaunch
Companies Healthcare 142280.KQ
14
142280.KQ KOSDAQ Medical Equipment, Supplies & Distribution

142280.Kq

$3 450,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
2,5 %
ROE
8,3 %
Net margin
3,4 %
Debt / equity
0,39
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Business. The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
8,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 142280.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 142280.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily generating revenue through the provision of medical equipment, supplies, and distribution services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company maintains a relatively balanced capital structure, with a debt-to-equity ratio of 0.39, indicating a moderate reliance on debt financing. Its liquidity position is characterized as medium, with a current ratio of 1.15, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company reported a net cash position that is negative after subtracting total debt, which may signal potential liquidity constraints in the near term.

    In terms of profitability, the company's return on equity (ROE) of 8.26% and return on assets (ROA) of 4.05% are key indicators of its efficiency in generating returns for shareholders and asset utilization, respectively. These figures should be compared against the industry median to determine whether the company is outperforming or underperforming its peers. The operating margin, derived from the operating income of 2,739,507,600 KRW on revenue of 108,413,453,300 KRW, suggests a healthy margin, but the exact industry median is required for a more precise assessment.

    The company's revenue is not segmented by geographic regions or product lines in the provided data, making it difficult to assess the geographic or segment concentration of its revenue. However, the absence of detailed segment data implies that the company may not have a highly diversified revenue base, which could expose it to regional or product-specific risks.

    The company's growth trajectory is not explicitly outlined in the provided data, but the financial snapshot does not indicate a significant change in revenue or operating income from the previous period. The outlook for the current and next fiscal years is not provided, so it is not possible to determine the expected direction of growth or the magnitude of the change.

    The risk assessment indicates a low potential for dilution, which is a positive sign for shareholders. However, the company's liquidity risk is rated as medium, which could be a concern if short-term obligations increase or if cash flow from operations is disrupted. The risk assessment does not provide a detailed breakdown of the sources of dilution, but the low rating suggests that the company is not currently issuing a large number of new shares or using other dilutive financing methods.

    There are no recent events, such as filings or transcripts, provided in the data to inform the company's current situation or strategic direction. The absence of such information means that the company's recent performance and strategic initiatives cannot be assessed in detail.

    Key takeaways
    • The company has a moderate debt-to-equity ratio, indicating a balanced capital structure.
    • The company's ROE and ROA are key indicators of its profitability and asset efficiency.
    • The company's liquidity position is medium, with a current ratio of 1.15.
    • The company's risk of dilution is low, which is favorable for shareholders.
    • The company's growth trajectory and strategic direction are not clearly outlined in the provided data.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $3 450,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $44.36B
    Net cash
    -$17.45B
    Current ratio
    1.1
    Debt / equity
    0.4
    ROA
    4.0%
    ROE
    8.3%
    Cash conversion
    196.0%
    CapEx / revenue
    -4.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin2,5 %Below median
    Net Margin3,4 %Below median
    ROE8,3 %Above P75
    Capex / Rev-4,3 %Above median
    D/E0,39Below median
    Cash Conv1,96Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 142280.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    142280.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage